ArticleEuropean radiology2026
US risk stratification system based on tumor burden for lateral lymph node metastasis in papillary thyroid carcinoma.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo develop a tumor burden score (TBS)-based risk stratification system (RSS) for preoperative discrimination of lateral lymph node metastasis (LLNM) and compare it with conventional US and TBS-only models. MATERIALS AND
methodsThis retrospective study included consecutive 404 adult patients diagnosed with PTC who underwent thyroid US and lateral lymph node dissection between January 2021 and October 2023. A prospective validation cohort was established with 174 patients enrolled from November 2023 to August 2024. Two novel tumor burden parameters, including D1/D2 and TBS score, were proposed. Logistic regression analyses were performed to assess associations between variables and LLNM in the training cohort. Features with p < 0.05 were incorporated into the LLNM RSS based on the Framingham risk score equation. Area under the receiver operating characteristic curve (AUC) was compared among the RSS, conventional US model, and TBS model in both cohorts.
resultsIn both training and validation cohorts, the RSS showed improved performance for identifying LLNM compared with the TBS model (AUC, 0.809 vs. 0.703, p < 0.01 and AUC, 0.752 vs. 0.634, p = 0.03), and in the training cohort, the AUC of the RSS was superior compared with the conventional US model (AUC, 0.809 vs. 0.732, p < 0.01). Furthermore, we identified clustered punctate echogenic foci (PEF) distributed along the periphery of primary tumors as a robust independent predictor of LLNM (OR = 3.157, 95% CI: 1.520-6.557).
conclusionThe user-friendly RSS constructed based on the tumor burden concept outperformed conventional US and TBS models for distinguishing LLNM in PTC preoperatively. KEY POINTS: Question To develop a risk stratification system (RSS) for the prediction of lateral lymph node metastasis (LLNM) in papillary thyroid carcinoma (PTC), addressing the limitations of first-line ultrasound. Findings The tumor burden-based RSS achieved superior accuracy (AUC = 0.81) versus the conventional ultrasound-based model (AUC = 0.70), effectively evaluating the risk of LLNM preoperatively. Clinical relevance The RSS incorporating tumor burden parameters and peripheral punctate echogenic foci sign demonstrates strong predictive value for LLNM and enables risk-stratified surgical planning, avoiding unnecessary lymph node dissection in low-risk PTC while identifying occult metastases in high-risk cases.
Indexed as
Identifiers
41326829What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.